Why Generic GTM Playbooks Don’t Work in Healthcare
(And why adapting them usually makes things worse)
Most healthcare GTM strategies start with a borrowed playbook. A framework that worked in SaaS, fintech, or verticalized B2B sales-led growth environments. Then it gets "customized for healthcare" with a few compliance slides and a longer sales cycle assumption.
The results are always the same: activity increases, pipelines look healthy, but revenue lags far behind effort. The problem isn’t execution. It is that generic GTM playbooks are built on assumptions healthcare fundamentally violates.
The Foundational Flaw: Flat-Market Thinking
Generic GTM playbooks assume markets where buyers self-identify, authority is visible, and interest predicts intent.
Healthcare is none of these.
Healthcare is layered, centralized in invisible places, governed by risk, and paced by timing. When GTM strategy flattens healthcare, it misfires at every step.
Why "Adaptation" Doesn't Fix the Problem
Most teams respond by lengthening sales stages or adding more personas. This doesn't solve the core issue. It assumes the underlying model is right and the friction is procedural.
In reality, the model itself is wrong. You can’t adapt a flat-market playbook to a layered decision system.
Where Generic Playbooks Break Step by Step
Let’s analyze the specific failures of traditional B2B models in healthcare.
1ICP Design Mistakes Authority for Interest
Generic ICPs define who should want the product. They don’t define who can approve, who controls contracts, or who bears risk.
In healthcare, the entity that wants a solution is often structurally unable to buy it. Targeting fails before execution begins.
2Persona Frameworks Confuse Usage with Power
Generic GTM emphasizes end users and economic buyers. Healthcare authority flows across clinicians, system leadership, payers, and external governance.
Generic persona models assume authority follows the org chart. In healthcare, authority follows risk and standardization.
3Funnel Stages Assume Linear Buying
Generic funnels move from awareness to purchase. Healthcare buying is recursive, committee-driven, and often paused by governance.
Deals don’t progress linearly; they wait for conditions to exist. Linear funnels turn waiting into false optimism.
4Lead-Driven GTM Ignores How Demand Forms
Generic playbooks assume leads create opportunities. Healthcare demand forms when operational pain becomes financial exposure and strategic risk.
Leads are not signals of readiness. They are often signals of curiosity.
5Messaging-First Strategy Overestimates Persuasion
In healthcare, persuasion is secondary to readiness. If governance isn’t aligned and risk isn’t visible, no message converts.
Healthcare doesn’t buy because it’s convinced. It buys because it’s compelled.
6CRM Becomes the Center of Strategy
CRM only sees engaged accounts and logged interactions. It cannot see external decision control, unengaged pressure, or parallel evaluations.
Healthcare GTM fails when strategy is built on what’s logged instead of what’s real.
Why Healthcare Exposes These Failures Faster
Other markets tolerate mis-targeting and early outreach. Healthcare does not. Mistakes compound because cycles are long, trust is fragile, and risk is existential.
What looks like "market resistance" is often just a model mismatch.
The Healthcare-Native Alternative
A healthcare-native go-to-market model requires a different starting point. Not tactics. Not channels. Not messaging. But decision intelligence.
This is the foundation Intent.Health is built on.
The Strategic Takeaway
Generic GTM playbooks don’t fail in healthcare because teams execute them poorly. They fail because they misunderstand how decisions are made, mistake interest for intent, and flatten a layered system.
Healthcare doesn’t need a customized playbook. It needs a different one entirely, built for ecosystems, risk, and timing. Until GTM strategy reflects that reality, effort will always outpace results.